SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Drug safety, crop protection and animal testing alternatives mulled at SOT

Employee safety is a focus for drugmakers and a growing market for the preclinical testing services sector according to Huntingdon Life Sciences.

Ergomed opens new office in Taiwan to meet growing Asian demand

UK-based risk-sharing CRO Ergomed has opened its first Asian office in Taiwan to strengthen its clinical research and consultancy presence in Asia.

PRA Health Sciences launches major early phase expansions

In another sign that early phase research demand is picking up, North Carolina-based CRO PRA Health Sciences (PRA) is increasing its Phase I clinical footprint in the US and Russia. 

Biorasi latest CRO to join Medidata's Rave party

Biorasi has become the latest CRO to ink a deal to use Medidata's Rave cloud-based clinical trial management technology.

CRO pricing power remains ‘elusive,’ analyst says

As biotech and mid-sized pharma companies continue to drive growth for CROs (contract research organizations), the expected ramping up of prices due to increased competition has yet to fully materialize, experts say.

PETA joins preclinical CROs at SOT to promote animal testing alternatives

Testing the toxicity of drug candidates in animals is archaic and unreliable according to PETA, which joined preclinical CROs at SOT to put forward alternatives.

Spotlight

Outsourcing market’s recently IPO'd stock prices see early spike

Outsourcing market’s recently IPO'd stock prices see early spike

Between May 2013, when Quintiles went public , and this week, newly public companies’ stocks in the biopharma...

US FDA working to make clinical trials less wasteful

US FDA working to make clinical trials less wasteful

The US FDA is looking to set up master protocols that can continuously run and help cut...

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision...

Strong USD to hit revenues but strategic CROs may see lower costs

Strong US Dollar to hit revenues but strategic CROs may see lower costs

The strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals...

Biosimulation – the next step in PK modelling embraced by regulators

Biosimulation – the next step in PK modelling embraced by regulators

Computer-based drug modelling is moving from a discovery aid to a clinical tool accepted by regulators, according...